NCT02935686 · Interventional trial
A Safety, Tolerability and Immunogenicity Study of 2 Different Regimens of Tetravalent Ad26.Mos4.HIV Prime Followed by Boost With Tetravalent Ad26.Mos4.HIV Along With Either Clade C gp140 Plus Adjuvant OR With a Combination of Mosaic and Clade C gp140 Plus Adjuvant in Healthy HIV Uninfected Adults
Overall registry status Completed
Phase 1 · Phase 2
Conditions Healthy
Delaware Valley sites
- University of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory